VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Vaccination with Gardasil
Preclinical
Biologic
A
Assistance Publique - Hôpitaux de Paris
1
Indications
3
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Cohort Study
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Cohort Study
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Cohort Study
1 trial
Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study
Unknown status
·
A
Assistance Publique - Hôpitaux de Paris
·
N/A
·
NCT05438953
·
164 enrolled
Immunogenicity
1 trial
Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease
Completed
·
A
Assistance Publique - Hôpitaux de Paris
·
Phase 2
·
NCT02274415
·
116 enrolled
Quadrivalent HPV Vaccine
1 trial
Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response
Unknown status
·
A
Assistance Publique - Hôpitaux de Paris
·
Phase 3
·
NCT03296397
·
300 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
3 trial records for Vaccination with Gardasil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Vaccination with Gardasil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Vaccination with Gardasil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
A
Assistance Publique - Hôpitaux de Paris
Related News